Search Results
Apr 01, 2026, 16:14 ET SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Centessa Pharmaceuticals plc (NASDAQ: CNTA)
CNTA) related to its sale to Eli Lilly and Company. Under the terms of the proposed transaction, Centessa shareholders are expected to receive $38.00
More news about: Monteverde & Associates PC
Mar 31, 2026, 12:00 ET Shareholder Alert: The Ademi Firm investigates whether Centessa Pharmaceuticals plc is obtaining a Fair Price for Public Shareholders
MILWAUKEE, March 31, 2026 /PRNewswire/ -- LLP is investigating Centessa (NASDAQ: CNTA) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Lilly.
More news about: Ademi LLP
Mar 31, 2026, 11:38 ET Are APLS, CNTA, BIRD Obtaining Fair Deals for their Shareholders?
multimedia:https://www.prnewswire.com/news-releases/are-apls-cnta-bird-obtaining-fair-deals-for-their-shareholders-302730253.htmlSOURCE
More news about: Halper Sadeh LLP
Mar 31, 2026, 06:45 ET Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders
LONDON, March 31, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage company developing a new class of medicines for the treatment of excessive daytime sleepiness and other neurological conditions, today
More news about: Eli Lilly and Company